Literature DB >> 24960541

Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients.

Swati Jadhav1, Rajeev Kasaliwal, Nitin S Shetty, Suyash Kulkarni, Krantikumar Rathod, Bhavesh Popat, Harshal Kakade, Amol Bukan, Shruti Khare, Sweta Budyal, Varsha S Jagtap, Anurag R Lila, Tushar Bandgar, Nalini S Shah.   

Abstract

CONTEXT: Tumor-induced osteomalacia is curable if the tumors can be totally excised. However, when the tumors are present in locations that make surgery disproportionately risky, the need for less invasive strategies like radiofrequency ablation (RFA) is realized. PATIENTS AND METHODS: We describe three patients with suspected tumor-induced osteomalacia who were treated in our department between 2006 and 2013 with tumors in surgically difficult locations and were subjected to single or multiple sessions of RFA. The response was documented in terms of symptomatic improvement, phosphorus normalization, and follow-up (99m)Technitium-labelled hydrazinonicotinyl-Tyr3-octreotide ((99m)Tc HYNIC TOC) scan.
RESULTS: Two of the three individuals, patient A (with a 1.5 × 1.2-cm lesion in the head of the right femur) and patient B (with a 1.3 × 1.2-cm lesion on the endosteal surface of the shaft of the left femur), achieved complete remission with single sessions of RFA. Three months after the procedure, (99m)Tc HYNIC TOC scans revealed the absence of uptake at the previous sites, corroborating with the clinical improvement and phosphorus normalization. Patient C had a large 5.6 × 6.5-cm complex lesion in the lower end of the left femur with irregular margins, loculations, and bone grafts placed in previous surgery. He failed to achieve remission after multiple sessions of RFA due to the complex nature of the lesion, although the tumor burden was reduced significantly as documented on serial (99m)Tc HYNIC TOC scans.
CONCLUSIONS: Although surgery remains the treatment of choice, RFA could be an effective, less invasive, and safe modality of treatment in judiciously selected patients.

Entities:  

Mesh:

Year:  2014        PMID: 24960541     DOI: 10.1210/jc.2013-4515

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Multimodality Image-Guided Cryoablation for Inoperable Tumor-Induced Osteomalacia.

Authors:  Sri Harsha Tella; Hayet Amalou; Bradford J Wood; Richard Chang; Clara C Chen; Cemre Robinson; Michelle Millwood; Lori C Guthrie; Sheng Xu; Elliot Levy; Venkatesh Krishnasamy; Rachel I Gafni; Michael T Collins
Journal:  J Bone Miner Res       Date:  2017-09-06       Impact factor: 6.741

2.  Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report.

Authors:  Sophie Cowan; Santiago A Lozano-Calderon; Raul N Uppot; Dipti Sajed; Ambrose J Huang
Journal:  Skeletal Radiol       Date:  2016-12-05       Impact factor: 2.199

3.  Reports of 17 Chinese patients with tumor-induced osteomalacia.

Authors:  Wei-Jia Yu; Jin-Wei He; Wen-Zhen Fu; Chun Wang; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2016-04-16       Impact factor: 2.626

4.  Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: A case report and review of the literature.

Authors:  Ejigayehu G Abate; Victor Bernet; Cherise Cortese; Hillary W Garner
Journal:  Bone Rep       Date:  2016-02-17

5.  Tumor-induced osteomalacia: experience from three tertiary care centers in India.

Authors:  Rimesh Pal; Sanjay Kumar Bhadada; Awesh Singhare; Anil Bhansali; Sadishkumar Kamalanathan; Manoj Chadha; Phulrenu Chauhan; Ashwani Sood; Vandana Dhiman; Dinesh Chandra Sharma; Uma Nahar Saikia; Debajyoti Chatterjee; Vikas Agashe
Journal:  Endocr Connect       Date:  2019-03       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.